|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu WH, Xiang YB, Zhang X, Ruan Z, Cai H,
Zheng W and Shu XO: Association of dietary glycemic index and
glycemic load with endometrial cancer risk among Chinese women.
Nutr Cancer. 67:89–97. 2015. View Article : Google Scholar
|
|
3
|
Gao J, Yang G, Wen W, Cai QY, Zheng W, Shu
XO and Xiang YB: Impact of known risk factors on endometrial cancer
burden in Chinese women. Eur J Cancer Prev. 25:329–334. PubMed/NCBI
|
|
4
|
Colombo N, Preti E, Landoni F, Carinelli
S, Colombo A, Marini C and Sessa C; ESMO Guidelines Working Group:
Endometrial cancer: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24(Suppl 6):
vi33–vi38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: Migrating cancer stem cells-an integrated
concept of malignant tumour progression. Nat Rev Cancer. 5:744–749.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and β-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG and
Weiss SJ: Canonical Wnt signaling regulates Slug activity and links
epithelial-mesenchymal transition with epigenetic breast cancer 1,
early onset (BRCA1) repression. Proc Natl Acad Sci USA.
109:16654–16659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang YW, Su YJ, Hsiao M, Wei KC, Lin WH,
Liang CL, Chen SC and Lee JL: Diverse targets of β-catenin during
the epithelial-mesenchymal transition define cancer stem cells and
predict disease relapse. Cancer Res. 75:3398–3410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Willert K, Brown JD, Danenberg E, Duncan
AW, Weissman IL, Reya T, Yates JR III and Nusse R: Wnt proteins are
lipid-modified and can act as stem cell growth factors. Nature.
423:448–452. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Du J, Zheng J, Liu J, Xu R, Shen
T, Zhu Y, Chang J, Wang H, Zhang Z, et al: EGF-reduced Wnt5a
transcription induces epithelial-mesenchymal transition via
Arf6-ERK signaling in gastric cancer cells. Oncotarget.
6:7244–7261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dissanayake SK, Wade M, Johnson CE,
O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal
DT, Indig FE, et al: The Wnt5A/protein kinase C pathway mediates
motility in melanoma cells via the inhibition of metastasis
suppressors and initiation of an epithelial to mesenchymal
transition. J Biol Chem. 282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamoto H, Oue N, Sato A, Hasegawa Y,
Yamamoto H, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is
involved in the aggressiveness of prostate cancer and expression of
metalloproteinase. Oncogene. 29:2036–2046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gujral TS, Chan M, Peshkin L, Sorger PK,
Kirschner MW and MacBeath G: A noncanonical Frizzled2 pathway
regulates epithelial-mesenchymal transition and metastasis. Cell.
159:844–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weigelt B, Peterse JL and van 't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sleeman J and Steeg PS: Cancer metastasis
as a therapeutic target. Eur J Cancer. 46:1177–1180. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wheelock MJ and Johnson KR: Cadherins as
modulators of cellular phenotype. Annu Rev Cell Dev Biol.
19:207–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clevers H: Wnt/β-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Tu C, Zhang D, Zheng Y, Peng Z,
Feng Y, Xiao S and Li Z: Wnt/β-catenin and Wnt5a/Ca2+
pathways regulate proliferation and apoptosis of keratinocytes in
psoriasis lesions. Cell Physiol Biochem. 36:1890–1902. 2015.
View Article : Google Scholar
|
|
26
|
Grumolato L, Liu G, Mong P, Mudbhary R,
Biswas R, Arroyave R, Vijayakumar S, Economides AN and Aaronson SA:
Canonical and noncanonical Wnts use a common mechanism to activate
completely unrelated coreceptors. Genes Dev. 24:2517–2530. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang E, Li Z, Xu Z, Duan W, Sun C and Lu
L: Frizzled2 mediates the migration and invasion of human oral
squamous cell carcinoma cells through the regulation of the signal
transducer and activator of transcription-3 signaling pathway.
Oncol Rep. 34:3061–3067. 2015.PubMed/NCBI
|
|
28
|
Scheel C, Eaton EN, Li SH, Chaffer CL,
Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, et al:
Paracrine and autocrine signals induce and maintain mesenchymal and
stem cell states in the breast. Cell. 145:926–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kandoth C, Schultz N, Cherniack AD, Akbani
R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al
Cancer Genome Atlas Research Network: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, van der Zee M, Fodde R and Blok
LJ: Wnt/B-catenin and sex hormone signaling in endometrial
homeostasis and cancer. Oncotarget. 1:674–684. 2010. View Article : Google Scholar
|
|
31
|
Wang Y, Hanifi-Moghaddam P, Hanekamp EE,
Kloosterboer HJ, Franken P, Veldscholte J, van Doorn HC, Ewing PC,
Kim JJ, Grootegoed JA, et al: Progesterone inhibition of
Wnt/β-catenin signaling in normal endometrium and endometrial
cancer. Clin Cancer Res. 15:5784–5793. 2009. View Article : Google Scholar : PubMed/NCBI
|
